Literature DB >> 24810919

A Quick Test of Cognitive Speed: norm-referenced criteria for 121 Italian adults aged 45 to 90 years.

Ferdinando Petrazzuoli1, Sebastian Palmqvist2, Hans Thulesius3, Nicola Buono1, Enzo Pirrotta1, Alfredo Cuffari1, Marco Cambielli1, Maurizio D'Urso1, Carmine Farinaro1, Francesco Chiumeo1, Valerio Marsala1, Elisabeth H Wiig4.   

Abstract

ABSTRACT Background: A Quick Test of Cognitive Speed (AQT) is a brief test that can identify cognitive impairment. AQT has been validated in Arabic, English, Greek, Japanese, Norwegian, Spanish, and Swedish. The aim of this study was to develop Italian criterion-referenced norms for AQT.
Methods: AQT consists of three test plates where the patient shall rapidly name (1) the color of 40 blue, red, yellow, or black squares (AQT color), (2) the form of 40 black figures (circles, squares, triangles, or rectangles; AQT form), (3) the color and form of 40 figures (consisting of previous colors and forms; AQT color-form). The AQT test was administered to 121 Italian cognitively healthy primary care patients (age range: 45-90 years). Their mean Mini-Mental State Examination (MMSE) score was 28.8 ± 0.9 points (range 26-30 points). AQT naming times in seconds were used for developing preliminary criterion cut-off times for different age groups.
Results: Age was found to have a significant moderate positive correlation with AQT naming times color (r = 0.65, p < 0.001), form (r = 0.53, p < 0.001), color-form (r = 0.63, p < 0.001) and a moderate negative correlation with MMSE score (r = -0.44, p < 0.001) and AQT naming times differed significantly between younger (45-55 years old), older (56-70 years old), and the oldest (71-90 years old) participants. Years of education correlated positively but weakly with MMSE score (r = 0.27, p = 0.003) and negatively but weakly with AQT color (r = -0.16, p = ns), form (r = -0.24, p = 0.007), and color-form (r = -0.19, p = 0.005). We established preliminary cut-off times for the AQT test based on +1 and +2 standard deviations according to the approach in other languages and settings. Conclusions: This is the first Italian normative AQT study. Future studies of AQT - a test useful for dementia screening in primary care - will eventually refine cut-off times for normality balancing sensitivity and specificity in cognitive diagnostics.

Entities:  

Year:  2014        PMID: 24810919     DOI: 10.1017/S1041610214000787

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  5 in total

1.  Stroop interference and AQT cognitive speed may play complementary roles in differentiating dementias with frontal and posterior lesions.

Authors:  Christy Fleck; Elisabeth H Wiig; Melinda Corwin
Journal:  Community Ment Health J       Date:  2014-06-28

2.  A systematic review and meta-analysis of studies on screening for mild cognitive impairment in primary healthcare.

Authors:  Leila Karimi; Alireza Mahboub-Ahari; Leila Jahangiry; Homayoun Sadeghi-Bazargani; Mostafa Farahbakhsh
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

3.  Reliability and validity of a quick test of cognitive speed (AQT) in screening for mild cognitive impairment and dementia.

Authors:  Pouya Farokhnezhad Afshar; Elisabeth H Wiig; Seyed Kazem Malakouti; Behnam Shariati; Sara Nejati
Journal:  BMC Geriatr       Date:  2021-12-15       Impact factor: 3.921

4.  A quick test of cognitive speed can predict development of dementia in Parkinson's disease.

Authors:  Mattis Jalakas; Sebastian Palmqvist; Sara Hall; Daniel Svärd; Olof Lindberg; Joana B Pereira; Danielle van Westen; Oskar Hansson
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

5.  Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline.

Authors:  Ferdinando Petrazzuoli; Susanna Vestberg; Patrik Midlöv; Hans Thulesius; Erik Stomrud; Sebastian Palmqvist
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.